We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

266 hedge funds and large institutions have $4.24B invested in Immunogen Inc in 2023 Q2 according to their latest regulatory filings, with 101 funds opening new positions, 67 increasing their positions, 72 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

426% more capital invested

Capital invested by funds: $805M → $4.24B (+$3.43B)

304% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 25

93% more call options, than puts

Call options by funds: $69.3M | Put options by funds: $35.8M

40% more funds holding

Funds holding: 190266 (+76)

7% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 72

Holders
266
Holders Change
+76
Holders Change %
+40%
% of All Funds
4.18%
Holding in Top 10
13
Holding in Top 10 Change
+13
Holding in Top 10 Change %
% of All Funds
0.2%
New
101
Increased
67
Reduced
72
Closed
25
Calls
$69.3M
Puts
$35.8M
Net Calls
+$33.4M
Net Calls Change
+$21.4M
Name Holding Trade Value Shares
Change
Change in
Stake
TD Asset Management
126
TD Asset Management
Ontario, Canada
$1.85M +$1.16M +97,900 New
SEC
127
Seven Eight Capital
New York
$1.83M +$1.15M +96,984 New
Group One Trading
128
Group One Trading
Illinois
$1.8M -$1.46M -123,642 -56%
BFM
129
Boothbay Fund Management
New York
$1.75M +$1.1M +92,751 New
Walleye Trading
130
Walleye Trading
New York
$1.73M +$1.08M +91,866 New
CM
131
Castleark Management
Illinois
$1.69M +$1.06M +89,460 New
BCM
132
Bayesian Capital Management
New York
$1.64M +$1.02M +86,682 New
CPM
133
Connective Portfolio Management
New York
$1.47M +$921K +78,000 New
E
134
Ergoteles
New York
$1.46M +$915K +77,537 New
TI
135
Trexquant Investment
Connecticut
$1.46M +$913K +77,367 New
SO
136
STRS Ohio
Ohio
$1.45M -$92.1K -7,800 -9%
PCM
137
Prelude Capital Management
New York
$1.44M +$902K +76,382 New
Squarepoint
138
Squarepoint
New York
$1.42M +$890K +75,376 New
HIS
139
Harvest Investment Services
Illinois
$1.41M +$882K +74,694 New
DekaBank Deutsche Girozentrale
140
DekaBank Deutsche Girozentrale
Germany
$1.31M
State Board of Administration of Florida Retirement System
141
State Board of Administration of Florida Retirement System
Florida
$1.3M -$17.6K -1,490 -2%
JCIA
142
Jackson Creek Investment Advisors
Colorado
$1.27M +$797K +67,489 New
TRSOTSOK
143
Teachers Retirement System of the State of Kentucky
Kentucky
$1.26M -$1.59M -135,075 -67%
PA
144
Profund Advisors
Maryland
$1.22M -$2.22M -188,111 -74%
TFCP
145
Twin Focus Capital Partners
Massachusetts
$1.21M -$354K -30,000 -32%
ASRS
146
Arizona State Retirement System
Arizona
$1.16M +$45.6K +3,863 +7%
CAPTRUST Financial Advisors
147
CAPTRUST Financial Advisors
North Carolina
$1.16M +$407K +34,482 +128%
UBS AM
148
UBS AM
Illinois
$1.13M
QPW
149
Quantum Private Wealth
Florida
$1.12M
Teacher Retirement System of Texas
150
Teacher Retirement System of Texas
Texas
$1.12M -$22.1K -1,870 -3%

IMGN Hedge Fund Activity: Q2 2023 in Review

266 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2023, worth a combined $4.24B — up 426% from $805M a quarter earlier.

Buyers outnumbered sellers: 101 funds opened new IMGN positions and 25 closed out — a net gain of 76 holders — while 67 added to existing stakes and 72 trimmed.

The largest buyer was Redmile Group, adding an estimated $114M. The largest seller was RA Capital Management, cutting an estimated $231M.

  • 266 institutional investors held Immunogen Inc (IMGN) as of Q2 2023, up from 190 in Q1 2023.
  • Funds reported $4.24B of Immunogen Inc stock for Q2 2023, up 426% quarter-over-quarter.
  • 101 funds opened new Immunogen Inc positions in Q2 2023 and 25 closed out, a net change of +76 holders.
  • The largest Immunogen Inc buyer in Q2 2023 was Redmile Group, an estimated $114M added.
  • The largest Immunogen Inc seller in Q2 2023 was RA Capital Management, an estimated $231M sold.

Based on aggregated 13F filings for Q2 2023.